Moreover, a recent study demonstrated that DSF combined with an anti-PD-1 Ab synergistically suppressed tumor growth by targeting FROUNT (also known as NUP85) function and elevated the number of CD8+ T cells in the tumors (29). Here, CD8A is linked to neoplasm.